Private Label Growth Oraceutical already provides development, licensing, and manufacturing services for third parties including CVS, Walgreens, Procter & Gamble, Ranir, Philips Sonicare, Premier Dental Products, IntelliWHITE, Virbac and others, and sells Smileactives whitening products directly to consumers via QVC. This positions the company to scale private label manufacturing and licensing deals with additional retailers and dental brands across consumer and professional channels.

Retail D2C Expansion With existing consumer sales through QVC and a portfolio of B2B partnerships, there is a clear path to broaden distribution through ecommerce platforms like Amazon, CVS.com, Walgreens.com, and dental distributors, complemented by co branded marketing with current partners to accelerate revenue growth.

Tech Licensing Growth Oraceutical’s model of developing and licensing dental technologies enables monetization through new licensing deals and private label products. Target brands seeking advanced whitening and oral care innovations can accelerate launches with lower capital requirements by leveraging Oraceutical’s research and development and manufacturing capabilities.

Scalable Operations Growth The lean team size suggests high agility to scale operations; formalizing sales, manufacturing capacity planning, and quality systems would support higher volume, geographic expansion, and more complex partnerships without sacrificing product quality.

Strategic Partner Expansion Existing partnerships with CVS, Walgreens, Procter & Gamble, Ranir, Philips Sonicare, Premier Dental and others create opportunities to expand SKUs, develop new whitening or oral care solutions, and enter new markets through partner networks.